✦ LIBER ✦

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

✍ Scribed by Professor Riccardo Rosso; Franco Salvati; Andrea Ardizzoni; Corrado Gallo Curcio; Alessandra Rubagotti; Mario Belli; Bruno Castagneto; Vittorio Fusco; Maurizio Sassi; Giuseppe Ferrara; Antonietta Pizza; Tonino Pedicini; Enzo Soresi; Sergio Scoditti; Riccardo Cioffi; Ugo Folco; Michele Monaco; Marco Merlano; Roberto Rimoldi; Riccardo Tonachella; Annarita Cruciani; Giuseppe Colantuoni; Massimo Rinaldi; Luigi Portalone; Paolo Bruzzi; Leonardo Santi

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 568 KB
Volume: 66
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900701)66:1<130::aid-cncr2820660123>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increasing dose intensity of cisplatin-e

Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma : A Phase III randomized trial of the Spanish lung cancer group

✍ Albert Font; Alfredo J. Moyano; Jose M. Puerto; Alejandro Tres; Carlos Garcia-Gi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Background: The authors designed this randomized, controlled trial to assess whether dose intensification of a cisplatin-etoposide combination (pe), achieved by shortening the interval between chemotherapy cycles, would improve response rate and survival. the maximum tolerated dose of pe was adm

Vindesine and high-dose cisplatin in the

Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer

✍ Fuks, Joachim Z. ;Patel, Halesh ;van Echo, David A. ;Hornedo, Javier ;Aisner, Jo 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

A randomized trial to compare intravenou

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer

✍ David H. Johnson; John C. Ruckdeschel; James H. Keller; Gary H. Lyman; Gerald J. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor

A randomized study of two vindesine plus

A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer

✍ R. Rosell; A. Abad-Esteve; I. Moreno; A. Barnadas; J. Carles; C. Fernandez; N. R 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

A randomized trial of hybrid administrat

A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/Cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma : Results of long term follow-up

✍ Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Haruhito Kamei; Kenichi Gemba; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## BACKGROUND. In an attempt to determine the efficacy of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) hybrid chemotherapy (HYB), a rapidly alternating chemotherapy, in patients with small cell lung carcinoma (SCLC), the authors conducted a randomized study to